TheraCann to License CertainT Platform for Legal Cannabis and Hemp

February 12, 2019

Read More

Applied DNA Reports FY’19 Q1 Results

February 7, 2019

Read More

Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN)

February 6, 2019

Read More

Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board

January 29, 2019

Read More

Tex-Ray to Introduce CertainT® to Global Textile Brands

January 28, 2019

Read More

Sun Chemical to Bring CertainT® to Textile Manufacturers in Asia

January 24, 2019

Read More

Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants

December 27, 2018

Read More

Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants

December 21, 2018

Read More

Applied DNA Announces Proposed Public Offering of Common Stock and Warrants

December 19, 2018

Read More